Quantification of prostate-specific antigen mRNA by coamplification with a recombinant RNA internal standard and microtiter well-based hybridization

Clinical Chemistry

Volumn 44, Issue 6, 1998, Pages 1170-1176

  Verhaegen, Monique ^a   Ioannou, Pinelopi C ^b   Christopoulos, Theodore K ^a  

^a UNIVERSITY OF WINDSOR   (Canada)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN DETECTION; ARTICLE; CANCER CELL CULTURE; FLUORESCENCE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; MALE; MOLECULAR RECOGNITION; PROSTATE ADENOCARCINOMA; QUANTITATIVE HISTOCHEMISTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031779603     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/44.6.1170     Document Type: Article

References (32)

1. Lu-Yao GL, Mclerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy. Time trends, geographic variation and outcomes. The Prostate Patient Outcome Research Team. JAMA 1993;269:2633-55.
2. Voges GE, McNeal JE, Redwine EA, Freiha FS, Stamey TS. Morphologic analysis of surgical margins with positive findings in prostatectomy for adenocarinoma of the prostate. Cancer 1992; 69:520-6.
3. Carter BS, Carter HB, Isaacs JT. The prostate: an increasing medical problem. Prostate 1990;16:187-97.
4. Corey E, Arfman EW, Liu AY, Vessella RL. Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin Chem 1997;43:443-52.
5. Pelkey TJ, Frierson HF, Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors [Review]. Clin Chem 1996;42:1369-81.
6. Rong H, Ji H, Pernow Y, Sjostedt U, Bucht E. Quantification of parathyroid hormone-related protein mRNA by competitive PCR and time-resolved lanthanide fluorometry. Clin Chem 1997;43: 2268-73.
7. Moreno JG, Croce CM, Fischer R, Monne M, Vihko P, Mulholland SG, et al. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res 1992;52:6110-2.
8. Katz AE, Olsson CA, Raffo AJ, Cama C, Seaman E, O'Toole KM, et al. Molecular staging of prostate cancer with use of an enhanced reverse transcriptase-PCR assay. Urology 1994;43:765-75.
9. Jaakkola S, Vornanen T, Leinonen J, Rannikko S, Stenman U. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen. Clin Chem 1995;41:182-6.
10. Katz AE, de Vries GM, Begg MD, Raffo AJ, Cama C, O'Toole K, et al. Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 1995;75:1642-8.
11. Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, et al. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 1995;13:1195-200.
12. Galvan B, Christopoulos TK, Diamandis EP. Detection of prostate specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry. Clin Chem 1995;41: 1705-9.
13. Gomella LG, Raj GV, Moreno JG. Reverse transcriptase polymerase chain reaction for prostate specific antigen for the management of prostate cancer [Review]. J Urol 1997;158:326-37.
14. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-4.
15. Deguchi T, Yang M, Ehara H, Ito S, Nishino Y, Takahashi Y, et al. Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer. Br J Cancer 1997;75: 634-8.
16. Wood DP, Banks ER, Humphreys S, McRoberts JW, Rangnekar VM. Identification of bone marrow micrometastases in patients with prostate cancer. Cancer 1994;74:2533-40.
17. Henke W, Jung M, Jung K, Lein M, Schlechte H, Berndt C, et al. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer 1997;70:52-6.
18. Jung K, Henke W, Lein M, Schnorr D, Loening SA. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells [Letter]. Cancer 1996;78:2445-7.
19. Henke W, Jung M, Jung K, Lein M, Schlechte H, Berndt C, et al. Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cells. Clin Chem 1996;42:1499-500.
20. Thiounn N, Saporta F, Flam TA, Pages F, Zerbib M, Vieillefond A, et al. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology 1997;50: 245-50.
21. Sokoloff MH, Tso CL, Kaboo R, Nelson S, Ko J, Dorey F, et al. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol 1996;156:1560-6.
22. Galvan B, Christopoulos TK. Quantitative reverse transcriptase-polymerase chain reaction for prostate-specific antigen mRNA. Clin Biochem 1997;30:391-7.
23. O'Hara SM, Veltri RW, Skirpstunas P, Hedican SP, Partin AW, Nelson JB, et al. Basal PSA mRNA levels detected by quantitative reverse transcriptase (Q-RT-PCR-PSA). subjects without prostate cancer [Abstract]. J Urol 1996;155:418A.
24. Ostrowski LE, Krieg P, Finch J, Cress AE, Nagle RB, Bowden GT. Expression of beta-actin during progression of mouse skin tumors. Carcinogenesis 1989;10:1439-44.
25. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993;15:532-6.
26. Riegman PHJ, Klaassen P, van der Korput JAGM, Romijn JC, Trapman J. Molecular cloning and characterization of novel prostate antigen cDNA's. Biochem Biophys Res Commun 1988;155: 181-8.
27. Bortolin S, Christopoulos TK, Verhaegen M. Quantitative polymerase chain reaction using a recombinant DNA internal standard and time-resolved fluorometry. Anal Chem 1996;68:834-40.
28. Chelly J, Concordet JP, Kaplan JC, Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA 1989;86:2617-21.
29. Diamandis EP, Yu H. Prostate cancer, prostate specific antigen and the polymerase chain reaction [Editorial]. Clin Chem 1995; 41:177-9.
30. Diamandis EP, Yu H. New biological functions of prostate specific antigen? J Clin Endocrinol Metab 1995;80:1515-7.
31. Lehrer S, Terk M, Piccoli SP, Song HK, Lavagnini P, Luderer AA. Reverse transcriptase-polymerase chain reaction for prostate specific antigen may be a prognostic indicator in breast cancer. Br J Cancer 1996;74:871-3.
32. Zarghami N, Diamandis EP. Detection of prostate-specific antigen mRNA and protein in breast tumors. Clin Chem 1996;42:361-6.